Company news
Median Technologies (EURONEXT:ALMDT) news
Every Median Technologies press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Median Technologies: H2 2026 Financial Communication Calendar
September 10, 2026
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31, 2026
September 8, 2026
Median Technologies Announces Formation of Strategic Review Committee and R&D Committee to Unlock Intrinsic Value and Accelerate Its eyon...
September 3, 2026
Median Technologies Announces Formation of Strategic Review Committee and R&D Committee to Unlock Intrinsic Value and Accelerate Its eyon...
September 2, 2026
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31, 2026
August 10, 2026
Median Technologies and Olea Medical, a Canon Medical Systems Company, Partner to Advance Commercial Deployment of AI-Powered eyonis® LCS...
July 30, 2026
Median Technologies Reports Record iCRO Backlog, Accelerates Commercial Rollout of eyonis® LCS and Development of New Indications Across ...
July 22, 2026
Median Technologies : Half Year Median Technologies liquidity contract statement – First half of 2026
July 15, 2026
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30, 2026
July 6, 2026
Median Technologies’ eyonis® LCS Obtains CE Marking
July 3, 2026
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31, 2026
June 8, 2026
Median Technologies Announces Successful Upsized Capital Increase of € 50 Million
June 3, 2026
Median Technologies Brings Forward Subscription Period of its €50 Million Capital Increase on the Back of Strong Demand from Institutiona...
June 1, 2026
Median Technologies Launches a Capital Increase of €40 million, with Potential Upsize to €50 million, to Support the Deployment of eyonis...
May 27, 2026
Median Technologies to Showcase iCRO’s Central and AI-powered Imaging Services for Oncology Clinical Trials at ASCO 2026
May 26, 2026
Median Technologies : Management Report of the Board of Directors – Financial Year Ended on Dec 31, 2025 – OEGM dated June 10, 2026
May 21, 2026
Median Technologies Announces the Availability of the Preparatory Documents for the Annual Shareholders’ Ordinary and Extraordinary Gener...
May 21, 2026
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of April 30, 2026
May 4, 2026
Median Technologies Reports Full-Year 2025 Financial Results and Provides Key Q1 2026 Business Highlights
April 23, 2026
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31, 2026
April 7, 2026
Median Technologies Achieves ISO 13485:2016 Certification for eyonis® Medical Device Quality Management System
March 18, 2026
Median Technologies Meets the Eligibility Conditions for the PEA-PME Scheme
March 13, 2026
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of February 28, 2026
March 9, 2026
Median Technologies to Showcase eyonis® LCS, Its AI/ML-based Software as a Medical Device for Lung Cancer Screening, at the European Cong...
March 2, 2026
Median Technologies to present at the TD Cowen 46th Annual Health Care Conference
February 27, 2026
Median Technologies to Host Webcasts Highlighting Strategic Advances Driving U.S. Deployment of eyonis® LCS
February 23, 2026
FDA Clearance Sets Stage for U.S. Commercialization of eyonis® LCS Software as a Medical Device for Lung Cancer Screening; Oran Muduroglu...
February 18, 2026
Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis® LCS Software as a Medical Device in the United States
February 12, 2026
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31, 2026
February 11, 2026
Median Technologies Receives FDA 510(k) Clearance for eyonis® LCS, the First AI Tech-Based Detection and Diagnosis Device for Lung Cancer...
February 9, 2026
Median Technologies Reports Landmark 2025 Performance With Major Regulatory and Commercial Milestones Ahead in 2026
January 19, 2026
Median Technologies: H1 2026 Financial Communication Calendar
January 14, 2026
Half Year Median Technologies Liquidity Contract Statement
January 7, 2026
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31, 2025
January 5, 2026
Median Technologies Partners With Leading U.S. Healthcare Company to Bring eyonis® LCS to Patients Across the U.S. and Europe
December 8, 2025
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30, 2025
December 3, 2025
Median Technologies to Showcase AI-Powered Software as a Medical Device eyonis® LCS for Lung Cancer Screening at the RSNA 2025 Annual Mee...
November 25, 2025
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31, 2025
November 13, 2025
Median Technologies Appoints Didric Cederholm to Its Board of Directors
November 3, 2025
Median Technologies Reports First-Half 2025 Financial Results and Provides Key Q3 2025 Business Results
October 23, 2025
Median Technologies Receives €19 Million From the European Investment Bank, Corresponding to the First Tranche Under the 2025 Loan Facility
October 21, 2025
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meet...
October 13, 2025
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30, 2025
October 6, 2025
Median Technologies Business Update Following Successful Financing
September 22, 2025
Median Technologies: H2 2025 Financial Communication Calendar
September 8, 2025
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31, 2025
September 4, 2025
Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31, 2025
August 7, 2025
Median Technologies Has Completed a Capital Increase of € 23.9 Million
August 1, 2025
CORRECTING and REPLACING: Following the signature of a financial agreement for up to €37.5 million with the EIB, Median Technologies laun...
July 23, 2025
Following the Signature of a Financial Agreement for up to €37.5 Million With the EIB, Median Technologies Launches an Approximately €22....
July 21, 2025